Delivery Order SPE2DR25D2214-SPE2DR26FV8B2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,189.06 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60 count) under a firm fixed price contract. The order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $52,050.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with a completion date of January 29, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $6.82K delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rifampin 300 mg capsules (60-count). The contract, which carries a firm fixed price and requires completion by December 3, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,928.15 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $31,201.41. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,384.52. This is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and represents a non-set-aside competitive award. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,685.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on a firm fixed-price basis. The contract, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Rifampin 300 mg capsules in quantities of 60 units, with a ceiling value of $6,960.94 and an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order structure and represents a task order under the company's broader pharmaceutical supply agreement with DLA Troop Support Medical. The place...
- On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,125.35 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsule unit dose packages (100 count). This firm fixed-price, competitively awarded contract (no set-aside designation) is scheduled for completion by January 15, 2026, with performance taking place at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,826.54. This is a firm fixed-price delivery order with an ultimate completion date of July 3, 2025, and represents a non-competitive set-aside. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV8B2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,601.07 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on January 29, 2026, with a completion date of January 30, 2026. This non-set-aside contract utilizes firm fixed-price pricing and is executed from the vendor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems and military medical supply chains. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical supply vehicle enables the company to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities, the Defense Health Agency, and other federal medical institutions globally. The contract award demonstrates AmerisourceBergen's competitive position as a critical vendor within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 1/28/26 |